Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer

BACKGROUND: Lung immune prognostic index (LIPI) status was recently developed to predict responses to immune checkpoint inhibitor (ICI) treatments. However, it is unclear whether LIPI is a prognostic index for both patients treated with ICI monotherapy and patients treated with ICIs combined with ch...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Front Oncol
Main Authors: Wang, Wenxian, Huang, Zhangzhou, Yu, Zongyang, Zhuang, Wu, Zheng, Weijun, Cai, Zhijian, Shi, Lei, Yu, Xinmin, Lou, Guangyuan, Hong, Wei, Zhang, Yiping, Chen, Ming, Song, Zhengbo
פורמט: Artigo
שפה:Inglês
יצא לאור: Frontiers Media S.A. 2020
נושאים:
Oncology
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7583465/
https://ncbi.nlm.nih.gov/pubmed/33163403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.572853
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים